Clinical trial
Multicenter, Randomized, Double-blind, Placebo Controlled, Study to Evaluate the Activity of a Ginger (Zingiber Officinale) Food Supplement in the Management of Nausea in Patients Receiving Highly Emetogenic Treatments and Standard Anti-emetogenic Therapy.
NCT01887314 is registered in ClinicalTrials.gov with Helsinn Healthcare SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Randomized, Double-blind, Placebo Controlled, Study to Evaluate the Activity of a Ginger (Zingiber Officinale) Food Supplement in the Management of Nausea in Patients Receiving Highly Emetogenic Treatments and Standard Anti-emetogenic Therapy.
- Lead sponsor
- Helsinn Healthcare SA
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- October 31, 2015
- Enrollment
- 250 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.